Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

A Real-Life Study of Autologous Stem-Cell Transplantation in Patients with Multiple Myeloma Older Than 65 Years in a Latin American Country

Cristian Maximiliano Seehaus, MD, Natalia Paola Schutz, MDMSc, Erika Barbara Brulc, MD, Leandro Burgos Pratx, MD, Gonzalo Ariel Ferini, MD, Jorge A Arbelbide, MD, Dorotea Fantl, MD, Ana Lisa Basquiera, MD PhD

Blood (2019) 134 (Supplement_1): 5711.

https://doi.org/10.1182/blood-2019-130171

Published: 2019

Journal Articles

Bleeding and Thrombotic Outcomes in Anticoagulant Free Extracorporeal Membrane Oxygenation (ECMO) in Adults: A Systematic Review

Cat R Murphree, MD, Joseph J Shatzel, MD, Sven R Olson, MD

Blood (2019) 134 (Supplement_1): 2436.

https://doi.org/10.1182/blood-2019-125132

Published: 2019

Journal Articles

Real-Time Electronic Health Registry Improves Care for Children with Sickle Cell Disease

Ashima Singh, PhD MS, Vanaja Danda, Julie Panepinto, MDMSPH

Blood (2019) 134 (Supplement_1): 4673.

https://doi.org/10.1182/blood-2019-123780

Published: 2019

Journal Articles

Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)

Samuel Slavin, MD, Andrew M. Brunner, MD, David P. Steensma, MD, Amir T. Fathi, MD, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD, Gregory A. Abel, MD MPH, Areej El-Jawahri, MD

Blood (2018) 132 (Supplement 1): 4750.

https://doi.org/10.1182/blood-2018-99-116434

Published: 2018

Journal Articles

Health Status of Offspring Conceived During Hydroxyurea Therapy for Sickle Cell Disease.

Saloni Tanna, MD, Betsy Clair, Sejal Kuthiala, MD, Teresa A. Coleman, MD, FACP, Abdullah Kutlar, MD

Blood (2009) 114 (22): 1533.

https://doi.org/10.1182/blood.V114.22.1533.1533

Published: 2009

Journal Articles

Psychological Correlates of Having Advance Care Planning in Patients with Hematological Malignancies.

Fausto R. Loberiza, Jr., M.D., M.S., Amy Sullivan, ScD, Robin Matsuyama, PhD, Roberta E Goldman, PhD, Stephanie J. Lee, MD, MPH

Blood (2009) 114 (22): 72.

https://doi.org/10.1182/blood.V114.22.72.72

Published: 2009

Journal Articles

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

Apar Kishor Ganti, MD, Stephanie J. Lee, MD, MPH, James O. Armitage, MD, Philip J. Bierman, MD, Gregory Bociek, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Elizabeth C. Reed, MD, Julie M. Vose, MD, Fausto Loberiza, MD, MS

Blood (2005) 106 (11): 2025.

https://doi.org/10.1182/blood.V106.11.2025.2025

Published: 2005

Journal Articles

Rituximab in the Treatment of Factor VIII Inhibitor.

Mercedes Maruscak, MSN, FNP, Barry Cohan, MD, Linda Aghakhanian, PA-C, Kalust Ucar, MD

Blood (2005) 106 (11): 4064.

https://doi.org/10.1182/blood.V106.11.4064.4064

Published: 2005

NARROW

A Real-Life Study of Autologous Stem-Cell Transplantation in Patients with Multiple Myeloma Older Than 65 Years in a Latin American Country

Bleeding and Thrombotic Outcomes in Anticoagulant Free Extracorporeal Membrane Oxygenation (ECMO) in Adults: A Systematic Review

Real-Time Electronic Health Registry Improves Care for Children with Sickle Cell Disease

Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)

Health Status of Offspring Conceived During Hydroxyurea Therapy for Sickle Cell Disease.

Psychological Correlates of Having Advance Care Planning in Patients with Hematological Malignancies.

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

Rituximab in the Treatment of Factor VIII Inhibitor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only